Cosentyx wins EU approval for first-line paediatric psoriasis
Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life
Read More
Author: Lucy Parsons
Genmab/Janssen’s Darzalex combo hits the mark in phase 3 study
Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint
Read More
Sanofi, GSK in advanced discussions with EU for COVID-19 vaccine
Supply deal could include up to 300 million doses of vaccine
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
